OROPHARYNX CANCER, STAGE I

Clinical trials for OROPHARYNX CANCER, STAGE I explained in plain language.

Never miss a new study

Get alerted when new OROPHARYNX CANCER, STAGE I trials appear

Sign up with your email to follow new studies for OROPHARYNX CANCER, STAGE I, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug trial aims to boost immune system to fight HPV throat cancer before surgery

Disease control Terminated

This study is testing if giving an immunotherapy drug called atezolizumab before surgery helps treat early-stage throat cancer caused by HPV. The drug aims to help the patient's own immune system attack the cancer. Researchers will give two doses to 20 patients, then check the tu…

Matched conditions: OROPHARYNX CANCER, STAGE I

Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control

Last updated Mar 30, 2026 14:30 UTC

OROPHARYNX CANCER, STAGE I

Get alerted when new OROPHARYNX CANCER, STAGE I trials appear

New drug trial aims to boost immune system to fight HPV throat cancer before surgery